Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001469348 | SCV001673428 | likely benign | not provided | 2024-05-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002561303 | SCV003543046 | uncertain significance | Inborn genetic diseases | 2021-08-17 | criteria provided, single submitter | clinical testing | The c.1043G>A (p.R348Q) alteration is located in exon 8 (coding exon 8) of the COL7A1 gene. This alteration results from a G to A substitution at nucleotide position 1043, causing the arginine (R) at amino acid position 348 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001826299 | SCV002079307 | likely benign | Epidermolysis bullosa dystrophica | 2019-12-27 | no assertion criteria provided | clinical testing |